Our findings underscore genetic studies that pinpoint a role for IL-23R-mediated pathways in IBD pathogenesis (Burton et al., 2007; Duerr et al., 2006) and provide insight into the mechanism of action of IL-23 in vivo. This evidence concerns the gene IL37 and inflammatory bowel disease.